Sonoma Biotherapeutics
Joe Arron is an accomplished Chief Scientific Officer with a distinguished background in biotechnology and genetics. With leadership experience at Sonoma Biotherapeutics and 23andMe, Joe has demonstrated expertise in advancing scientific research and innovation. Prior to these roles, Joe served as a Postdoctoral Scholar at Stanford University, further enhancing a robust foundation in scientific inquiry and development.
This person is not in any teams
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.